These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 29497351)
1. Controlling Stochasticity in Epithelial-Mesenchymal Transition Through Multiple Intermediate Cellular States. Ta CH; Nie Q; Hong T Discrete Continuous Dyn Syst Ser B; 2016 Sep; 21(7):2275-2291. PubMed ID: 29497351 [TBL] [Abstract][Full Text] [Related]
2. Integrative Transcriptomic Analysis Reveals a Multiphasic Epithelial-Mesenchymal Spectrum in Cancer and Non-tumorigenic Cells. Panchy N; Azeredo-Tseng C; Luo M; Randall N; Hong T Front Oncol; 2019; 9():1479. PubMed ID: 32038999 [TBL] [Abstract][Full Text] [Related]
3. An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States. Hong T; Watanabe K; Ta CH; Villarreal-Ponce A; Nie Q; Dai X PLoS Comput Biol; 2015 Nov; 11(11):e1004569. PubMed ID: 26554584 [TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition proceeds through directional destabilization of multidimensional attractor. Wang W; Poe D; Yang Y; Hyatt T; Xing J Elife; 2022 Feb; 11():. PubMed ID: 35188459 [TBL] [Abstract][Full Text] [Related]
5. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Huang RY; Wong MK; Tan TZ; Kuay KT; Ng AH; Chung VY; Chu YS; Matsumura N; Lai HC; Lee YF; Sim WJ; Chai C; Pietschmann E; Mori S; Low JJ; Choolani M; Thiery JP Cell Death Dis; 2013 Nov; 4(11):e915. PubMed ID: 24201814 [TBL] [Abstract][Full Text] [Related]
6. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311 [TBL] [Abstract][Full Text] [Related]
7. Energy Landscape Analysis of the Epithelial-Mesenchymal Transition Network. Ye L; Li C Methods Mol Biol; 2022; 2488():145-157. PubMed ID: 35347688 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms. Li D; Xia L; Huang P; Wang Z; Guo Q; Huang C; Leng W; Qin S Cell Prolif; 2023 Jun; 56(6):e13423. PubMed ID: 36808651 [TBL] [Abstract][Full Text] [Related]
10. A plausible accelerating function of intermediate states in cancer metastasis. Goetz H; Melendez-Alvarez JR; Chen L; Tian XJ PLoS Comput Biol; 2020 Mar; 16(3):e1007682. PubMed ID: 32155144 [TBL] [Abstract][Full Text] [Related]
11. Mathematical Modeling of Plasticity and Heterogeneity in EMT. Tripathi S; Xing J; Levine H; Jolly MK Methods Mol Biol; 2021; 2179():385-413. PubMed ID: 32939734 [TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. Chen T; You Y; Jiang H; Wang ZZ J Cell Physiol; 2017 Dec; 232(12):3261-3272. PubMed ID: 28079253 [TBL] [Abstract][Full Text] [Related]
13. Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer. Esquer H; Zhou Q; Nemkov T; Abraham AD; Rinaldetti S; Chen YC; Zhang X; Orman MV; D'Alessandro A; Ferrer M; Messersmith WA; LaBarbera DV Oncogene; 2021 Apr; 40(16):2884-2897. PubMed ID: 33742123 [TBL] [Abstract][Full Text] [Related]
14. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness. Liao TT; Yang MH Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800 [TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs and nuclear architecture during epithelial-mesenchymal transition in lung cancer and idiopathic pulmonary fibrosis. Rubio K; Castillo-Negrete R; Barreto G Cell Signal; 2020 Jun; 70():109593. PubMed ID: 32135188 [TBL] [Abstract][Full Text] [Related]
16. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response. Jia D; Li X; Bocci F; Tripathi S; Deng Y; Jolly MK; Onuchic JN; Levine H J Clin Med; 2019 May; 8(5):. PubMed ID: 31121840 [TBL] [Abstract][Full Text] [Related]
17. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT). Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424 [TBL] [Abstract][Full Text] [Related]
18. EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity. Zhu N; Xu X; Wang Y; Zeng MS; Yuan Y PLoS Pathog; 2021 Aug; 17(8):e1009873. PubMed ID: 34407150 [TBL] [Abstract][Full Text] [Related]
19. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression. Sinha D; Saha P; Samanta A; Bishayee A Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810 [TBL] [Abstract][Full Text] [Related]
20. Hybrid Epithelial-Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors. Selvaggio G; Canato S; Pawar A; Monteiro PT; Guerreiro PS; Brás MM; Janody F; Chaouiya C Cancer Res; 2020 Jun; 80(11):2407-2420. PubMed ID: 32217696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]